# A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

> **NCT06942793** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 396 (estimated)

## Conditions studied

- Dry Eye Disease

## Interventions

- **DRUG:** CsA-PG Ophthalmic Gel
- **DRUG:** CsA Ophthalmic Gel

## Key facts

- **NCT ID:** NCT06942793
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-20
- **Primary completion:** 2025-10-20
- **Final completion:** 2025-11-15
- **Target enrollment:** 396 (ESTIMATED)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06942793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06942793, "A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06942793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*